The complex ethical issues arising from the development of the gene editing technology and the synthetic biology technology are reviewed in this paper. The common ethical disputes among the natural life view, the traditional culture view, the technological security and the social justice are analyzed, as well as the ethical differences in the ethical consequences, the ethical attitudes and the ethical governance. By developing a reasonable ethical reflection approach, the complex ethical challenges faced by the modern biotechnology and the scientific ethical position that should be upheld are prospected. This paper provides some guidance for the formulation of the forward-looking and targeted classified governance countermeasures in the future, to make the development of science and technology and the social ethics in harmony for the benefit of mankind.
[1] Randhawaa S, Sengar S. The evolution and history of gene editing technologies[J]. Progress in Molecular Biology and Translational Science, 2021(178): 1-62.
[2] Sun T, Song J, Wang M, et al. Challenges and recent progress in the governance of biosecurity risks in the era of synthetic biology[J]. Journal of Biosafety and Biosecurity, 2022(4) : 59-67.
[3] 陈高华. 基因编辑技术的现实道德困境及其消解路径[J]. 医学与哲学, 2021, 42(2): 28-33.
[4] 陆群峰. 人类基因编辑的伦理问题探析[J]. 自然辩证法研究, 2020, 36(1): 68-73.
[5] Agapito-Tenfen S Z, Okoli A S, Bernstein M J, et al. Revisiting risk governance of GM plants: The need to consider new and emerging gene-editing techniques[J]. Frontiers in Plant Science, 2018(9): 1-16.
[6] Kaebnick G E, Gusmano M K, Murray T H. The ethics of synthetic biology: Next steps and prior questions[J]. Hastings Center Report, 2014, 44(S5): S4-S26.
[7] 李真真, 董永亮, 高旖蔚. 设计生命: 合成生物学的安全风险与伦理挑战[J]. 中国科学院院刊, 2018, 33(11): 1269-1276.
[8] 蒲强, 罗嘉, 沈林園, 等. CRISPR/Cas9基因组编辑技术的研究进展及其应用[J]. 中国生物工程杂志, 2015(11): 77-84.
[9] Opinion on synthetic biology I definition[EB/OL]. (2014-09-25)[2021-04-11]. https://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_044.pdf.
[10] Keiper F, Atanassova A. Regulation of synthetic biology: Developments under the convention on biological diversity and its protocols[J]. Frontiers in Bioengineering and Biotechnology, 2020(8): 1-20.
[11] 马诗雯. 合成生物学的伦理学反思——一种责任视角[D]. 大连: 大连理工大学哲学系, 2020: 5.
[12] 卢俊南, 褚鑫, 潘艳萍, 等. 基因编辑技术： 进展与挑战[J]. 中国科学院院刊, 2018, 33(11): 1184-1192.
[13] Srinivas K R. Governance of emerging technologies/applications in the bio/life sciences: Genome editing and synthetic biology[M]//Chaurasia A, Hawksworth D L, Miranda M P. GMOs: Implications for biodiversity conservation and ecological processes. Cham: Springer Nature Switzerland AG, 2020: 441-462.
[14] 刘思敏, 郭卫华. 道家“自然生命观” 视域下对“基因编辑技术” 的哲学思考[J]. 中国医学伦理学, 2020, 33(6): 690-694.
[15] 樊浩. 基因技术的道德哲学革命[J]. 中国社会科学, 2006(1): 123-134.
[16] 杨磊, 翟晓梅. 合成生命的伦理问题及其管理建议[J]. 中国医学伦理学, 2012, 25(3): 273-276.
[17] Dabrock P. Playing god? Synthetic biology as a theological and ethical challenge[J]. Systems & Synthetic Biology, 2009(3): 47-54.
[18] 周树峰. 生物伦理学[M]. 厦门: 厦门大学出版社, 2019: 342.
[19] Gómez-Tatay L, Hernández-Andreu J M. Biosafety and biosecurity in synthetic biology: A review[J]. Crit Rev Environ Sci Technol, 2019, 49(17): 1587-1621.
[20] 彭耀进. 合成生物学时代: 生物安全、 生物安保与治理[J]. 国际安全研究, 2020(5): 29-57.
[21] Tucker J B, Zilinskas R A. The promise and perils of synthetic biology[J]. The New Atlantis, 2006(12): 25-45.
[22] 王前, 刘洪佐. 机体哲学视域下基因编辑技术的伦理反思[J]. 伦理学研究, 2020(2): 108-113.
[23] 张慧, 李秋甫, 李正风. 合成生物学的伦理争论: 根源、 维度与走向[J]. 科学学研究, 2022, 40(4): 577-585.
[24] Ahteensuu M. Synthetic biology, genome editing, and the risk of bioterrorism[J]. Science and Engineering Ethics, 2017(23): 1541-1561.
[25] Synthetic biology[EB/OL]. (2019-8-14) [2021-05-23]. https://www. genome. gov/about-genomics/policy-issues/ Synthetic-Biology.
[26] Guo M, Liu H, Du R, et al. Advances in bacterial multiplex genome engineering and its applications in synthetic biology[J]. Biotechnology Bulletin, 2018, 34(5): 22-31.
[27] 汪珍, 王晓生. 基因密码破译的生命伦理规制[J]. 科学技术哲学研究, 2020, 37(3): 117-122.
[28] 孙道锐. 基因编辑的法律限度[J]. 中国科技论坛, 2020(6): 153-160.
[29] 姚恒美. 国内外基因编辑技术相关政策规划[EB/OL]. (2020-11-26) [2021-05-12]. http://www. istis. sh. cn/list/ list.aspx?id=12984.
[30] 刘旭霞, 刘桂小. 基因编辑技术应用风险的法律规制[J]. 华中农业大学学报(社会科学版), 2016(5): 125-131.
[31] 张军, 李笑蕾, 任跃明. 中国与欧盟、 美国基因治疗产品安全性监管研究[J]. 中国药事, 2021, 35(4): 368- 379.
[32] 梁慧刚, 黄翠, 宋冬林, 等. 合成生物学研究和应用的生物安全问题[J]. 科技导报, 2016, 34(2): 307-312.
[33] German Central Committee on Biological Safety(ZKBS). Synthetic biology[R]. Berlin: ZKBS, 2018.
[34] 美国科学院研究理事会.合成生物学时代的生物防御[M]. 郑涛, 叶玲玲, 程瑾, 等译. 北京: 科学出版社, 2020.
[35] 中国科学院颠覆性技术创新研究组. 颠覆性技术创新研究： 生命科学领域[M]. 北京: 科学出版社, 2020: 131. [J]. 医学与哲学, 2021, 42(2): 28-33.
[4] 陆群峰. 人类基因编辑的伦理问题探析[J]. 自然辩证法研究, 2020, 36(1): 68-73.
[5] Agapito-Tenfen S Z, Okoli A S, Bernstein M J, et al. Revisiting risk governance of GM plants: The need to consider new and emerging gene-editing techniques[J]. Frontiers in Plant Science, 2018(9): 1-16.
[6] Kaebnick G E, Gusmano M K, Murray T H. The ethics of synthetic biology: Next steps and prior questions[J]. Hastings Center Report, 2014, 44(S5): S4-S26.
[7] 李真真, 董永亮, 高旖蔚. 设计生命: 合成生物学的安全风险与伦理挑战[J]. 中国科学院院刊, 2018, 33(11): 1269-1276.
[8] 蒲强, 罗嘉, 沈林園, 等. CRISPR/Cas9基因组编辑技术的研究进展及其应用[J]. 中国生物工程杂志, 2015(11): 77-84.
[9] Opinion on synthetic biology I definition[EB/OL]. (2014- 09-25)[2021-04-11]. https://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_044.pdf.
[10] Keiper F, Atanassova A. Regulation of synthetic biology: Developments under the convention on biological diversity and its protocols[J]. Frontiers in Bioengineering and Biotechnology, 2020(8): 1-20.
[11] 马诗雯. 合成生物学的伦理学反思——一种责任视角[D]. 大连: 大连理工大学哲学系, 2020: 5.
[12] 卢俊南, 褚鑫, 潘艳萍, 等. 基因编辑技术： 进展与挑战[J]. 中国科学院院刊, 2018, 33(11): 1184-1192.
